MENU
CVKD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cadrenal Therapeutics (CVKD) Ownership - Who owns Cadrenal Therapeutics?

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy... Show more

Profile

Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
24.52M
P/E Ratio
N/A
Total Cash
7.34M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.73
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

CVKD
Capitalization
24.5M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
7.34M
Total Cash/Share
3.73
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
6.11M
P/B Ratio
4.01
Cash Flow
N/A
Earnings
-9.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.91K
Current Ratio
4.32
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-12.82M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-171.09
Shares Held By Institutions
1.38M
Shares Outstanding - Current
1.97M
Total Liabilities
1.84M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-13.941
View a ticker or compare two or three
CVKD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
822 A1A North
Phone
+1 904 300-0701
Employees
4
Web
https://www.cadrenal.com